Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • 03 Health Services

    April 25, 2019 |  

    How Pharma Companies Can Survive the Patent Cliff Through Digital Innovation

    The pharma market is about to get busy. 2011–2013 marks a patent cliff, when many big-selling drugs went, or soon will go, off patent. 2013–2015 promises several new products jostling for attention. This time the stakes are even higher than usual, and companies will need to get their new products firmly established to secure future revenues. They will also be launching into a fast-evolving digital ecosystem.

    Specific products will offer different medical merits but their success will depend on how effectively brands can blend digital into their launch process — and how much value dynamic digital services add to the product offering. Many areas of healthcare have already been busy harnessing the potential of digital in innovative technical ways: gene sequencing, diagnostic imaging, telemedicine, electronic medical records, and so on.

    Many believe that pharmaceutical marketing has been slow to find the relevance of digital innovation for standard consumer offerings, but the potential to capitalise on technology for health is limitless. Where entertainment and retail may offer services and interactions that people want, healthcare has the opportunity to create services that people need.

    This content was provided by Havas Lynx

    Documents for download:

    Company Details

    - PMLiVE

    Havas Lynx

    Email
    Website

     Latest Content from  Havas Lynx 

    Doctored Truths urges pharma to lead the fight against health misinformation

    “Doctored Truths” exposes the escalating crisis of health misinformation and disinformation, which has been ranked the world’s top short-term risk to the world, for the second year in a row....

    Havas Lynx Welcomes New Leadership Hires

    Havas Lynx announces the appointment of Ayesha Walawalkar as Chief Strategy Officer, and Talin Apkarian as Havas Lynx Hudson Managing Director.

    Havas to Open New Manchester Village at Circle Square

    The global communications group will unite six agencies under one roof in a purpose-built, hybrid workspace at the heart of Manchester’s innovation district

    Havas Lynx launches proprietary data product to drive meaningful change across pharma

    Leading global healthcare communications agency, Havas Lynx , has launched its proprietary data platform, Point.1, to help pharmaceutical companies to gain a deeper understanding of healthcare professionals (HCPs) to drive...

    Healing the Healers

    Because if we do not heal the healers, who is going to heal us?

    THE HIDDEN LIFESAVERS: overdose prevention campaign launches nationwide

    The campaign encourages people who use drugs to do something remarkable – save a life

    Andi Goes – the children’s book that helps detect early signs of dyslexia

    Havas Lynx Group have launched a children’s book aimed at raising awareness and detecting early signs of dyslexia. Helping to make sure that parents have the support they need whilst...

    Neurofibromatosis: a condition that’s hard to say, but even harder to live with

    The Childhood Tumour Trust and Havas Lynx Group have launched a campaign to raise awareness and funds for people living with a rare genetic condition, neurofibromatosis 1 (NF1).

    Havas Health & You Launches Behind the Mask, a Global Research Initiative to Document Health Experiences During the COVID-19 Pandemic and Beyond

    Havas Health & You (HH&Y) have launched the details of a long-term global research project, Behind the Mask, a longitudinal, multi-armed study which focuses on documenting the ongoing evolution of...

    Media Means Business

    Creating meaningful media experiences in pharma